Company Profiles

driven by the PitchBook Platform

Accuronix Therapeutics

Accuronix Therapeutics
2015 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$625k LATEST DEAL AMOUNT
$650k TOTAL AMOUNT RAISED
2 INVESTORS
Description

Developer of novel therapies designed to solve most difficult problems in cancer therapy. The company's novel therapies is based on technology that selectively targets σ-2 receptors overexpressed on cancer cells, enabling doctors to increase efficacy and reduce toxicity risk.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
20 South Sarah Street
Saint Louis, MO 63108
United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Accuronix Therapeutics’s full profile, request a free trial.

Accuronix Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 28-Jan-2016 $625k $650k Completed Startup
1. Early Stage VC 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Accuronix Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BioGenerator Not-For-Profit Venture Capital Minority 000 0000 000000 0
Missouri Technology Venture Capital Minority 000 0000 000000 0

Accuronix Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Dennis Schafer Chief Executive Officer & President
Linda Law Vice President, Clinical Development & CMO
Robert Mach Ph.D Co-Founder
William Hawkins Co-Founder

Accuronix Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Charles Bolten BioGenerator Board Member 000 0000